Autologous cell salvage in off-pump coronary artery bypass surgery reduces post-operative complications: a...

Area of Science:

• Cardiovascular Surgery
• Transfusion Medicine
• Anesthesiology

Background:

• Blood transfusion is critical in coronary artery bypass grafting (CABG).
• The choice between autologous cell salvage (CS) and allogeneic blood transfusion (ABT) remains debated in cardiac surgery.
• Off-pump CABG (OPCAB) involves complex perioperative management.

Purpose of the Study:

• To compare perioperative outcomes of OPCAB patients receiving cell salvage (CS) alone versus allogeneic blood transfusion (ABT) or a combination.
• To evaluate the impact of transfusion strategies on complications, recovery, and resource utilization.

Main Methods:

• Retrospective analysis of 414 patients undergoing isolated OPCAB surgery.
• Patients were divided into two groups: CS alone (n=250) and ABT or ABT+CS (n=164).
• Stabilized inverse probability treatment weighted (IPTW) matching was used to balance covariates.

Main Results:

• No significant difference in 30-day mortality between CS and ABT groups.
• The CS group showed significantly lower rates of overall complications, including stroke, acute kidney injury, atrial fibrillation, and pulmonary issues.
• CS group had shorter median lengths of hospital stay (LOHS), ICU stay, and ventilation time, with more home discharges.

Conclusions:

• Autologous blood transfusion via cell salvage (CS) is associated with fewer perioperative complications after OPCAB.
• CS facilitates faster patient recovery and reduced hospital resource utilization compared to ABT.
• CS represents a potentially superior transfusion strategy for OPCAB procedures.